2025 CancerX Accelerator Cohort – Where Innovation Meets Collaboration
CancerX shared a post on LinkedIn:
“What an incredible journey with our 2025 CancerX Accelerator cohort!
Watching these 14 innovative startups showcase their breakthrough solutions on June 24th was nothing short of inspiring. From 66 cross-champion connections to 35 deal opportunities developed, this cohort has shown us what’s possible when innovation meets collaboration.
We’re incredibly proud of each startup and its champion partners, who have worked together to accelerate solutions that will transform cancer care. The partnerships formed, pilots launched, and breakthroughs achieved remind us why we do this work.
The future of oncology innovation has never looked brighter.
Ready for what’s next? We can’t wait to welcome the 2026 cohort and continue building a world where cancer breakthroughs happen faster, together.
STAY TUNED: Applications open September 2025.”
Proceed to the video attached to the post.
More posts featuring CancerX on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023